0139 SUVN-G3031, A Potent and Selective Histamine H3 Receptor Inverse Agonist - Phase-2 Investigational New Drug for the Treatment of Narcolepsy - Differentiating Factors with Competitor Clinical Candidates

[摘要] IntroductionSUVN-G3031 is one of the potent H3 receptor (H3R) inverse agonist in the clinical development for the treatment of narcolepsy with or without cataplexy. Phase-1 evaluation for safety, tolerability and pharmacokinetics, and long term safety studies in animals has been successfully completed.

[学科分类] 生理学